If you have bacterial vaginosis (BV),
prescription NUVESSA® can...
Treat your BV with just one dose
If you have bacterial
vaginosis (BV),
prescription NUVESSA® can...
Treat your BV with just one dose
In a clinical study Nuvessa® demonstrated statistically significantly higher cure rates over a Control Gel.
NUVESSA® is a prescription medicine used to treat bacterial vaginal infections in females 12 years of age and older.
It is not known if NUVESSA® is safe and effective in female children younger than 12 years of age.
Treat BV in a single dose at bedtime with 1-dose
NUVESSA®1
NUVESSA® comes in a prefilled, single-dose disposable applicator.
*Single-dose NUVESSA® is administered once intravaginally.1
†The patient is responsible for the first $25 of their co-pay and cash-paying
patients should pay approximately $55. For cash paying patients or insured patients when
NUVESSA® is not covered by primary insurance, patients may still use this savings card but
may have an outstanding balance.
Please see Program Terms, Conditions, and Eligibility Criteria on back of card
or here.
Pay as little as $25† for your prescription
If you’re eligible, you can use the savings card at the pharmacy when you pick up
your prescription and pay as little as $25†on one prescription
fill.
*Single-dose NUVESSA® is administered once intravaginally.1
†The patient is responsible for the first $25 of their co-pay and cash-paying patients
should pay approximately $55. For cash paying patients or insured patients when NUVESSA® is
not covered by primary insurance, patients may still use this savings card but may have an
outstanding balance.
Please see Program Terms, Conditions, and Eligibility Criteria on back of card
or here.
IMPORTANT RISK INFORMATION
What is the most important information I should know about NUVESSA® (metronidazole
vaginal gel 1.3%)
Do not use NUVESSA® if you:
Are allergic to metronidazole, parabens, nitroimidazole derivatives, or any of the ingredients
in NUVESSA®.
Take, or have taken in the last 2 weeks, a medicine called Antabuse® (disulfiram).
Are not willing to or cannot abstain from alcohol. Do not drink alcohol while you use
NUVESSA® and for at least 24 hours after you stop using it.
Before you use NUVESSA®, tell your doctor about all your medical conditions, including if you:
Have or had central nervous system diseases.
Are pregnant or plan to become pregnant. It is not known if NUVESSA® will harm your unborn
baby. Tell your doctor if you become pregnant during treatment with NUVESSA®.
Are breastfeeding or plan to breastfeed. NUVESSA® can pass into breast milk and may harm
your baby. You should not breastfeed while using NUVESSA® and for 2 days after treatment.
Talk with your doctor about the best way to feed your baby while using NUVESSA®.
Tell your doctor about all of the medicines you take, including prescription and
over-the-counter medicines, vitamins, and herbal supplements. NUVESSA and certain other medicines
can affect each other, especially medicine that contains warfarin or other coumarin blood thinners,
or lithium.
NUVESSA® may cause serious side effects, including:
Convulsive seizures and weakness, numbness, or pain in the arms and legs. Tell your doctor right
away if these symptoms or neurologic changes develop.
Abnormal blood tests. NUVESSA® may cause changes in certain blood tests, such as those for
liver enzymes, triglycerides, and blood sugar.
What are the possible side effects of NUVESSA®?
In adults, the most common side effects of NUVESSA® were: yeast infection, headache,
vaginal itching, nausea, diarrhea, and menstrual cramps.
In patients 12 to less than 18 years old, the most common side effect was vulvovaginal
discomfort.
What should I avoid while using NUVESSA®?
Do not consume ethanol (alcohol) or propylene glycol during, and for at least 24 hours after,
you stop using NUVESSA®.
Do not have vaginal intercourse or use other vaginal products (such as tampons or douches).
These are not all the side effects of NUVESSA®.
To learn more, talk about NUVESSA® with
your doctor or pharmacist.
INDICATION
What is NUVESSA®?
NUVESSA® is a prescription medicine used to treat bacterial vaginal infections in females 12
years of age and older. It is not known if NUVESSA® is safe and effective in female children younger
than 12 years of age.
Tell your healthcare provider if you have any side effects. You can report side effects at 1-800-FDA-1088 or
www.fda.gov/medwatch.
Please click here for full Prescribing Information and Patient Information for NUVESSA®
What is the most important information I should know about NUVESSA® (metronidazole
vaginal gel 1.3%)
Do not use NUVESSA® if you:
Are allergic to metronidazole, parabens, nitroimidazole derivatives, or any of the ingredients
in NUVESSA®.
Take, or have taken in the last 2 weeks, a medicine called Antabuse® (disulfiram).
Are not willing to or cannot abstain from alcohol. Do not drink alcohol while you use
NUVESSA® and for at least 24 hours after you stop using it.
Before you use NUVESSA®, tell your doctor about all your medical conditions, including if you:
Have or had central nervous system diseases.
Are pregnant or plan to become pregnant. It is not known if NUVESSA® will harm your unborn
baby. Tell your doctor if you become pregnant during treatment with NUVESSA®.
Are breastfeeding or plan to breastfeed. NUVESSA® can pass into breast milk and may harm
your baby. You should not breastfeed while using NUVESSA® and for 2 days after treatment.
Talk with your doctor about the best way to feed your baby while using NUVESSA®.
Tell your doctor about all of the medicines you take, including prescription and
over-the-counter medicines, vitamins, and herbal supplements. NUVESSA and certain other medicines
can affect each other, especially medicine that contains warfarin or other coumarin blood thinners,
or lithium.
NUVESSA® may cause serious side effects, including:
Convulsive seizures and weakness, numbness, or pain in the arms and legs. Tell your doctor right
away if these symptoms or neurologic changes develop.
Abnormal blood tests. NUVESSA® may cause changes in certain blood tests, such as those for
liver enzymes, triglycerides, and blood sugar.
What are the possible side effects of NUVESSA®?
In adults, the most common side effects of NUVESSA® were: yeast infection, headache,
vaginal itching, nausea, diarrhea, and menstrual cramps.
In patients 12 to less than 18 years old, the most common side effect was vaginal discomfort.
What should I avoid while using NUVESSA®?
Do not consume ethanol (alcohol) or propylene glycol during, and for at least 24 hours after,
you stop using NUVESSA®.
Do not have vaginal intercourse or use other vaginal products (such as tampons or douches).
These are not all the side effects of NUVESSA®.
To learn more, talk about NUVESSA® with
your doctor or pharmacist.
INDICATION
What is NUVESSA®?
NUVESSA® is a prescription medicine used to treat bacterial vaginal infections in females 12
years of age and older. It is not known if NUVESSA® is safe and effective in female children younger
than 12 years of age.
Tell your healthcare provider if you have any side effects. You can report side effects at 1-800-FDA-1088 or
www.fda.gov/medwatch.
Please click here for full Prescribing Information and Patient Information for NUVESSA®
You are entering a site reserved for U.S. healthcare professionals only. By clicking on “Yes” below, you are confirming that you are a healthcare professional and wish to enter this site.
You are entering a site reserved for U.S. healthcare professionals only. By clicking on “Yes” below, you are confirming that you are a healthcare professional and wish to enter this site.
Sorry: this page is reserved for U.S. Healthcare Professionals only.
Program Terms, Conditions, and
Eligibility Criteria
:
Dear Pharmacist: The patient is responsible for the first $25 of their co-pay
and cash-paying patients should pay approximately $55. Card is good for refills through
12/31/19. Prescriber ID# required on prescription. Not valid for individuals enrolled in
Medicare, Medicaid, a state pharmaceutical assistance program, or any other federal or state
health care program.
Patient Instructions: In order to redeem this card you must have a valid
prescription for NUVESSA®. The patient is responsible for the first $25 of their co-pay
and cash-paying patients should pay approximately $55. Card is good for refills through
12/31/19. Follow the dosage instructions given by the doctor. This card may not be redeemed for
cash. You are not eligible for this offer if you are enrolled in Medicare, Medicaid, or
any other federal or state healthcare program. Cardholders with questions, please
call 1-844-558-2650
Pharmacist Instructions for a Patient with an Eligible Third Party Payer:
Submit the claim to the primary Third Party Payer first, then submit the balance due to
Change Healthcare as a Secondary Payer COB [coordination of benefits] with
patient responsibility amount and a valid Other Coverage Code, (e.g. 8). The
patient is responsible for the first $25 of their co-pay. Reimbursement will be received from
Change Healthcare.
Pharmacist Instructions for a Cash-Paying Patient: Submit this claim to
Change Healthcare. A valid Other Coverage Code (e.g. 1) is
required. The patient is responsible for the first $25 of their co-pay and cash-paying patients
should pay approximately $55. Reimbursement will be received from Change
Healthcare.
Valid Other Coverage Code required. For any questions regarding Change
Healthcare online processing, please call the Help Desk at 1-800-422-5604.
Program managed by ??? on behalf of Alembic Therapeutics. The parties reserve the right to rescind, revoke, or amend this offer without notice at any time. Not valid if reproduced. Void where prohibited by law.
Privacy Policy
Last updated: February 2026
Thank you for visiting this website (this “Site”), which is owned and operated by Alembic Therapeutics LLC (“Alembic,” “we,” “us,” or “our”). This Privacy Policy (“Policy”) describes how we collect, use, disclose, and otherwise process information collected through the Site and the choices available to you regarding such information.
Scope of This Policy
This Policy applies solely to information collected through the Site on which it is posted. It does not apply to information collected through any other websites, mobile applications, or online services operated by Alembic on which this Policy is not posted, nor does it apply to information collected through offline channels, such as by telephone, mail, or in person.
This Policy also does not apply to information collected in connection with participation in a clinical trial or clinical study conducted pursuant to an Institutional Review Board (IRB)-approved protocol. Such activities are governed by separate informed consent forms, clinical trial documentation, and applicable research privacy notices.
Some of the information we collect through the Site constitutes “personal information,” meaning information that identifies, relates to, describes, or could reasonably be linked to an identified or identifiable individual. Other information may be aggregated, de-identified, or otherwise not reasonably identifiable.
This Policy may be supplemented or amended by additional privacy notices (“Privacy Notices”) provided at the point of collection, which describe specific data practices associated with particular pages or interactions. In the event of a conflict between this Policy and a Privacy Notice, the Privacy Notice will control with respect to the specific interaction.
Your Consent
By accessing or using the Site, you consent to the collection, use, disclosure, storage, and processing of your information as described in this Policy and any applicable Privacy Notices. If you do not consent, you must not access or use the Site.
Relationship to Terms of Use
This Policy forms part of the Terms of Use governing your use of the Site. A link to the Terms of Use is available at the bottom of each page of the Site. Any dispute arising out of or relating to this Policy shall be subject to the dispute resolution provisions set forth in the Terms of Use.
Information We Collect
Personal Information You Voluntarily Provide
We collect information that you voluntarily submit through the Site, including when you complete forms, submit inquiries, request information, or otherwise interact with the Site. This information may include your name, contact information, professional credentials, and any health-related or eligibility information you choose to provide. Any information collected through the Site is used primarily to respond to user requests and to administer Site features such as access to savings or support programs.
The Site is not intended to collect information subject to the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Any health-related information submitted through the Site is collected as consumer-provided information and not as protected health information. To the extent required under applicable state privacy laws, such health-related information is treated as sensitive personal information and subject to heightened safeguards. Information submitted through the Site is not monitored for adverse event reporting or product complaint intake and should not be used for such purposes.
Information Collected Automatically
When you access the Site, we automatically collect certain technical and usage information, including your IP address, browser type and version, operating system, referring URLs, date and time of access, and pages viewed. We use this information to administer the Site, monitor performance, enhance security.
Cookies and Similar Technologies
We may use cookies, web beacons, pixels, and similar technologies to support Site functionality and enhance security. These technologies help us understand how users navigate the Site, which pages are visited, and how long users remain on the Site.
You may configure your browser to refuse cookies or alert you when cookies are being sent. Please note that disabling cookies may limit certain Site features. Alembic does not currently deploy a separate cookie consent banner and relies on browser-level controls for managing cookie preferences.
Third-Party Analytics and Advertising Technologies
Alembic may use limited third-party service providers to support basic website hosting, security, and technical operations. These providers are not authorized to use personal information for their own purposes.
Alembic does not sell personal information or share personal information for cross-context behavioral advertising and therefore does not respond to Global Privacy Control (GPC) browser signals.
We may use information collected through the Site to:
Respond to inquiries, requests, or communications.
Administer, operate, and improve the Site.
Identify individuals eligible for clinical research opportunities, subject to informed consent.
Perform internal administrative and operational activities.
Protect the security and integrity of the Site.
Comply with applicable laws, regulations, and legal processes.
Enforce our Terms of Use and other agreements.
How We Share Information
Service Providers and Vendors
We may share information with third-party service providers that perform services on our behalf, such as website hosting, IT support, and security services. These providers are contractually required to use personal information only for the purposes specified by Alembic and to maintain appropriate safeguards.
Research and Study Partners
If you submit information through the Site to assess potential eligibility for a clinical study, we may share relevant information with research partners or study sites solely to permit them to contact you regarding potential participation. Any subsequent participation is governed by separate informed consent documentation.
Legal and Business Disclosures
We may disclose information as required by law, regulation, court order, or governmental request, or when we believe disclosure is necessary to protect the rights, property, or safety of Alembic, Site users, or others.
Business Transfers
In the event of a merger, acquisition, reorganization, or sale of assets, personal information may be transferred as part of the transaction, subject to continued protection consistent with this Policy or a successor policy.
Aggregated or De-Identified Information
We may use and disclose aggregated or de-identified information for any lawful purpose.
Data Security
We implement reasonable administrative, technical, and physical safeguards designed to protect information from unauthorized access, disclosure, alteration, or destruction. These measures include encryption of data in transit and restricted access controls. Despite these efforts, no security system is impenetrable, and we cannot guarantee absolute security.
Children’s Privacy
The Site is not intended for children under the age of 13, and we do not knowingly collect personal information from children under 13. If we become aware that such information has been collected, we will take appropriate steps to delete it.
Your Privacy Rights
Depending on your state of residence, you may have certain rights regarding your personal information, including the right to request access to, correction of, or deletion of personal information, and the right to obtain a copy of information in a portable format.
California Residents
California residents have the right to request disclosure of the categories and specific pieces of personal information collected, the purposes for collection, and the categories of third parties with whom information is shared. California residents may also request correction or deletion of personal information. Alembic does not sell personal information or share personal information for cross-context behavioral advertising.
Other U.S. State Residents
Residents of certain other U.S. states may have similar rights, including the right to appeal our response to a privacy request. Appeals may be submitted by contacting us using the information below.
Exercising Your Rights
Requests to exercise privacy rights may be submitted by contacting us at compliance@alembictx.com. We may take reasonable steps to verify your identity before responding to a request, including requesting information sufficient to confirm your identity and residency. We will respond to verified requests within the timeframes required by applicable law. If we deny a request, you may appeal our decision by contacting us at the same email address, and we will respond to such appeals in accordance with applicable law.
Data Retention
We retain personal information for as long as reasonably necessary to fulfill the purposes for which it was collected, comply with legal obligations, resolve disputes, and enforce agreements.
International Data Transfers
Alembic is a U.S.-based company, and information collected through the Site may be stored and processed in the United States or other jurisdictions that may not provide the same level of data protection as your home jurisdiction. By using the Site, you consent to such transfers in accordance with this Policy.
Changes to This Policy
We may update this Policy from time to time by posting a revised version on the Site. The “Last Updated” date above indicates when this Policy was most recently revised. Your continued use of the Site after any changes constitutes acceptance of the updated Policy.
Governing Law
This Policy is governed by the laws of the State of New Jersey, without regard to conflict-of-laws principles.
Contact Us
If you have questions or concerns about this Policy or our data practices, please contact:
Alembic Therapeutics LLC
Email: compliance@alembictx.com
TERMS AND CONDITIONS OF USE
1. CONTROLLER’S IDENTITY:
The website https://nuvessa.com (hereinafter, the “Website”) owned by Alembic Therapeutics, LLC (hereinafter, “Alembic”), with registered offices at 180 Park Ave, Suite 101 Florham Park, NJ 07932 and Tax Identification 22-1942453. Alembic, and all the subsidiaries dedicated to pharma sector are globally known as Alembic Pharmaceuticals Ltd., (hereinafter, “Alembic Pharmaceuticals”).
Alembic welcomes you, and strongly recommends to read carefully the following Terms and Conditions of Use (hereinafter, the “Terms and Conditions”) which explain the terms and conditions that will be applicable to your navigation through the Website in accordance with U.S. Federal and state of New Jersey laws. Alembic may modify these Terms and Conditions in the future, therefore we recommend you to review periodically this agreement in order to be properly informed on the changes.
With the purpose of making the Website as transparent, plain and simple as possible, you (hereinafter, the “User”) will be able to send any question or request related to the Terms and Conditions by contacting Alembic by email, sending your request to compliance@alembictx.com
The User undertakes to use the services and utilities provided by the Website in accordance with current legislation, these Terms and Conditions and moral standards, good practice and public order.
2. OBJECT:
Alembic provides the contents and the services available in the Website which will be governed by these Terms and Conditions and the Cookies and Privacy Policy that you, as “User”, expressly accept to have read and understood.
Access or use of the Website confers you the condition of User, this means your full acceptance of these Terms and Conditions which will be available on the Website. Alembic reserves the right, at our sole discretion, to modify or replace this Terms and Conditions at any moment. It will be responsibility of the User to read carefully these Terms and Conditions each time he visits the Website, if the User disagrees with any of these Terms and Conditions he must refrain from using the Website.
Likewise, we inform you that Particular Conditions for the use of specific contents or services of the Website could be established, if you use the mentioned contents or services it will imply your acceptance of the Particular Conditions.
3. ACCESS AND USE OF THE WEBSITE:
The User is aware and expressly and voluntarily accepts that using the Website will be at his own risk and responsibility.
When using the Website, the User is fully committed to avoid any behaviour that could harm Alembic’ or third parties reputation, interests, rights or use the Website in a way that causes, or is likely to cause any damage or an interruption in the normal use of the Website.
Alembic implements reasonable security measures for virus detection. Nonetheless, the User must be aware that security measures are not entirely trustworthy and Alembic cannot guarantee the non-existence of viruses or other elements which might produce alterations in your systems (software and hardware), electronic documents and data files included in them.
4. WEBSITE CONTENT:
Alembic offers the User the following possibilities
Learn more about NUVESSA®.
If of healthcare professional standing, ability to submit a medical question or request samples to be sent to office.
Download Savings Cards to save on NUVESSA® prescription at pharmacy.
Contact information with Pharmacovigilance Department.
5. PRIVACY AND COOKIES POLICY
In accordance with the provisions of the U.S. Federal and State laws, as well as European Data Protection Regulation, Alembic informs you on the existence of automated and non-automated files owned by Alembic where data collected through the Website is stored. Likewise, the California Consumer Privacy Act of 2018 (CCPA) gives consumers with their residence in California the right to know what categories of personal data are collected and processed and how and for what purposes Alembic shall use and share that information.
For additional information please read our Privacy Policy and Cookies Policy.
6. INTELLECTUAL PROPERTY
The User acknowledges and accepts that all the contents displayed on the Website and especially, designs, texts, images, logos, icons, buttons, software, trademarks, or any other sign susceptible of industrial use and / or commercial are subject to Intellectual Property rights and all trademarks, or distinctive signs, all rights of industrial and intellectual property, content and/or any other element included in the page, which are the exclusive property of Alembic Pharmaceuticals, who has the exclusive right to use them in economic traffic. Therefore, the User agrees to not reproduce copy, distribute, make available or otherwise publicly communicate, transform or modify such content, holding Alembic or Alembic Pharmaceuticals harmless from any claim arising from the breach of such obligations.
In any case the access to the Website implies any type of waiver, transfer, license or total or partial assignment of the mentioned rights, unless expressly stated otherwise. These Terms and Conditions do not confer on the User any other right of use, alteration, exploitation, reproduction, distribution or public communication of the Website and / or its contents other than those expressly provided herein. Any other use or exploitation of any right will be subject to the prior and express authorization specifically granted for this purpose by Alembic Pharmaceuticals, or by the third party owner of the affected rights.
The contents, texts, photographs, designs, logos, images, software, source codes and, in general, any intellectual creation existing on this Website, as well as the site, as a multimedia artistic work, are protected as copyright by Intellectual Property legislation. Alembic Pharmaceuticals owns the elements that make up the graphic design of the Website, menus, navigation buttons, HTML code, texts, images, textures, graphics and any other content of the Website or, in any case, they have the corresponding license for the use of said elements. The content provided on the Website may not be reproduced in whole or in part, nor transmitted, nor recorded by any information retrieval system, in any form or in any medium, unless prior authorization is granted, for written, of the mentioned company.
Likewise, it is forbidden to delete, ignore and / or manipulate the "copyright" as well as the technical protection devices, or any information mechanism that the contents may contain. The User of this Website undertakes to respect the mentioned rights and to avoid any action that could harm them, Alembic or Alembic Pharmaceuticals reserve in any case the exercise of any legal actions in defence of its intellectual and industrial property legitimate rights.
7. USER’S OBLIGATIONS AND RESPONSIBILITIES
The User hereby undertakes to refrain from using the Website for any purpose forbidden by these Terms and Conditions. The User is responsible and liable for the use of the Website. Furthermore, the User shall comply with any obligation required by the applicable legislation.
The User, in addition, must: (i) have the means and meet the technical requirements that are required to access the Website and make use of the available services through it; and (ii) provide truthful information when filling out the forms contained in the Website with his personal data and keeping them updated at all times, responding at all times to the User's current situation. The User will be solely responsible for the false or inaccurate statements and the damages caused to Alembic related to the information provided.
The User must also refrain from:
Making an unauthorized or fraudulent use of the Website and / or content for illegal purposes or the ones prohibited in these Terms and Conditions, harmful to the rights and interests of third parties, or in any way that may damage, disable, overload, deteriorate or prevent the normal use of the services, documents, files and all kinds of content stored on any computer;
Accessing or attempting to access restricted resources or areas of the Website, without complying with the conditions required for the mentioned access;
Causing damage to the physical or logical systems of the Website, its suppliers or third parties;
Introducing viruses in the network computer or any other physical or logical system that is likely to cause damage to the physical or logical systems of Alembic or third parties;
Attempting to access, use and / or manipulate Alembic’s and other Users data. Reproduce, copy, distribute, allow public access through any form of public communication, transform or modify the contents, unless you have the authorisation of the owner of the rights or it is legally permitted;
Deleting, hiding or manipulating the information on intellectual or industrial property rights and other data identifying the rights of Alembic , Alembic Pharmaceuticals or third parties incorporated into the contents, as well as technical protection devices or any information mechanism that can be inserted in the contents;
Obtaining or attempting to obtain contents using means or procedures other than the ones that have been made available for this purpose or have been expressly indicated on the websites where the contents are or, in general, of those that are commonly used on the Internet because they do not involve a risk of damage or disablement of the Website and / or the contents;
The User undertakes to not transmit, disseminate or make available to third parties information, data, content, messages, graphics, drawings, sound and/or image files, photographs, recordings, software and, in general, any kind of material that may:
In any way, is contrary or violate the fundamental rights and freedoms recognized by the U.S. Federal and State laws, International Treaties and any other valid and applicable legislation;
Induce or promote actions of a criminal nature, slanderous, defamatory, violent or, in general, contrary to the law, morality, generally accepted good practices or public order activities;
Induce or promote discriminatory actions, attitudes or feelings based on sex, race, religion, beliefs, age or sexual condition;
Gather, make available or allow access to products, elements, messages and / or services of a criminal nature, violent, offensive, harmful, degrading or, in general, contrary to law, morality and generally accepted good practices or public order;
Induce or may induce to an unacceptable state of anxiety or fear;
Induce or promote to participate in dangerous, risky or harmful practices for health and psychic balance;
Is protected by the intellectual or industrial property legislation belonging to Alembic or Alembic Pharmaceuticals, without having authorized the intended use;
It is contrary to honour, personal and familiar privacy or people' s own image;
Constitutes any type of non-consensual advertising;
Include any virus or program that prevents the normal use of the Website.
8. LIMITATION OF LIABILITY
Alembic will be responsible for ensuring, except for force majeure reasons, the proper functioning of the Website, avoiding technical inconvenience and any other actions that may limit and / or partially interrupt the use thereof by Users.
Alembic does not guarantee continued access, or the correct viewing, downloading or use of the elements and information contained in the pages linked to this Website, and that may be impeded, hindered or interrupted by factors or circumstances beyond its control. Alembic is not responsible for the decisions that may be adopted as a result of access to contents or information offered through these linked sites.
Alembic may interrupt the service or immediately terminate the relationship with the User if it detects that a use of its Website or any of the services offered therein is contrary to these Terms and Conditions. Alembic shall not be responsible for damages, losses, claims or expenses derived from the use of the Website. It will only be responsible for deleting, as soon as possible, the contents that may generate such damages, provided that this is notified. In particular, it will not be responsible for the damages that could be derived, among others, from:
Interferences, interruptions, failures, omissions, telephone breakdowns, delays, blockages or disconnections in the electronic systems, caused by deficiencies, overloads and errors in telecommunication networks, or by any other cause beyond the control of Alembic;
Illegitimate intromissions through the use of malicious programs of any kind and through any means of communication, such as viruses or any other;
Improper or inappropriate abuse of the Website;
Security or navigation errors caused by a malfunction of the browser or by the use of non-updated versions thereof;
Alembic excludes any liability for damages of any nature due to the misuse of the available services by Website Users. Likewise, Alembic will be exempt from any responsibility related to content and information that may be received as a result of an illegal or incorrect use of said services.
9. INDEMNITY OF Alembic
The User shall protect, indemnify and hold Alembic harmless from any loss or damage arising from claims, actions or demands of third parties as a result of its use of the Website. Likewise, the User shall indemnify Alembic against any damages arising from the use of "robots", "spiders", "crawlers" or similar tools used for the purpose of collecting or extracting data or any other action that imposes an unreasonable burden on the use of the Website.
Access to the services or contents provided through the Website will be made under the exclusive responsibility of the Users. In case of minors or incapacitated persons, the responsibility will correspond to their parents, representatives or legal guardians, who must supervise or take the necessary precautions during their navigation through the web pages.
If you negligently or wilfully fail to comply with any of the obligations set forth in these Terms and Conditions, you will be liable for all damages and losses that may arise for Alembic related to the breach.
10. CHANGE OF CONTROL
In the event that Alembic is acquired by or merged with a third party entity, Alembic reserves the right to transfer or assign its contractual position as well as the information collected from the Users as part of such merger, acquisition, sale, or other change of control.
The third entity shall comply with the requirements states by Alembic in the Terms and Conditions and in the Cookies and Privacy Policy.
11. INTERNATIONAL USE AND LANGUAGE
The use of the Website by the User located at a country other than the United States will be under the responsibility of the User. The User is solely responsible to comply with the laws of the countries from which he uses the Website.
The present conditions may be translated into certain languages to ensure that they can be read and understood by all of our users, they are aware and accept that always the English version shall prevail in the assumption that might exist contradictions between the different versions and that these conditions are subject to federal and state of New Jersey laws.
12. CHANGES IN THE TERMS AND CONDITIONS
We reserve the right, at our sole discretion, to modify or replace these Terms and Conditions. When this happens, a notice will be included on the Website indicating and informing Users that modifications have been made.
13. NULLITY AND INEFFICIENCY OF THE CLAUSES
If any clause included in these Terms and Conditions is declared totally or partially invalid, null and void, such invalidity or nullity will only affect the mentioned provision or the part that is null or ineffective, while the remaining parts of these Terms and Conditions will continue to apply, considering such provision totally or partially as not included.
14. GOVERNING LAW AND JURISDICTION
The relationship between Alembic and the User will be governed under the laws of the State of New Jersey in force and any dispute will be submitted to the Courts of NewJersey, renouncing to any other venue they may be subjected to. Alembic will pursue the breach of these Terms and Conditions, as well as any improper use of the Website by exercising all civil and criminal actions that may correspond by law.
This California Policy describes how Alembic Therapeutics, LLC. as part of Alembic Pharmaceuticals, Ltd. and all its subsidiaries located in third countries (hereinafter, jointly referred to as “Alembic”) processes the information collected from users located in California (the “California Consumer”) when registering or navigating through the website https://nuvessa.com(hereinafter, the “Website”), owned by Alembic Therapeutics, LLC. In case users not located in California, this California Policy does not apply to them.
Alembic and all its subsidiaries located in the EU or third countries are globally known as Alembic Pharmaceuticals (hereinafter, “Alembic Pharmaceuticals”). Please find additional information about Alembic Pharmaceuticals and a non-exhaustive list of Alembic subsidiaries here.
Please read carefully this Privacy Policy as it contains important information concerning the personal information of California Consumers and how we use it in accordance with the California Consumer Privacy Act of 2018 (CCPA). This Policy supplements our Privacy Policy.
Alembic dedicates all its efforts to respect the privacy and security of the Users and undertakes to use personal data in accordance with applicable data protection laws.
2. Categories of personal information and purposes of the processing
California Consumer may use some functionalities of the Website without having to provide Alembic any personal information. However, for certain functions, California Consumer shall provide personal information in order to register for certain services, receive newsletters or other information of interest. In addition to the information provided directly to Alembic, we collect certain information when you visit our Website.
Calilfornia User has the right to know what personal information is collected, how it is used and business purposes. Below we make available this information for each of our business purpose.
A. Users communications and customer service
The categories or Personal Information collected through these business purposes may include:
contact and identity information;
relationship information;
health or other sensitive information;
online or technical details;
as well as any other type of personal information that California Customer may consider necessary to communicate with us.
Personal Information shall be processed for the sole purposes of solving any incident, claim, suggestion or request made by California Customer.
The legal basis for the processing of these personal information is consent when the California User provide their data through the contact forms.
B. Pharmacovigilance
The Personal Information provided by California Customer for pharmacovigilance purposes will be used solely to manage any incident regarding adverse effects that may be communicated by California Customer. This Personal Information is based in the consent shown when California Consumer fulfil and send specific form available on our web.
This Personal Information may include:
contact and identity information;
relationship information;
health or other sensitive information;
online or technical details;
transaction information;
as well as any other type of personal information needed to manage adverse effects and pharmacovigilance purposes.
C. Newsletter and commercial communications
If case California Customer subscribes to any of our notification or messaging services, we will use the email address provided by the California Customer to provide the service.
If the California Customer has subscribed to any product, service or functionality, we may also communicate with the User to inform him or her of other similar products or candidatures that may be of interest.
The California Customer can at any time unsubscribe of these communications by using the opt-out feature enable in e-mail messages or contacting dataprotecion@alembicusa.com
The legal basis for this processing is the consent, when the California Customer checks the box enabled in specific forms. Likewise, Alembic, based on its legitimate interest, may send the California Customer information about similar products and services. We will delete your email address once you have opted out, unless it is also used for any other purposes listed in this Privacy Policy.
D. Marketing
Information about California Customer online searches (clicks and views), settings on our Website, requests for information and/or their contact history may be subject to processing by Alembic. Personal Information collected for these purposes will be:
Contact information;
Online and tracking information;
Cookie data;
IT and navigation information.
This Personal Information allows us to use different means to manage the relations with our customers and commercialize our products and services through e-mail or online advertising which may include customizing the content of the Website and offers in order to suit user preferences. Marketing communication shall be made in accordance with Electronic Communications Privacy Act and any other applicable law. You may at any time object to this processing.
We use this personal data based on our legitimate interest to improve our products and services. Personal data will generally be deleted or anonymised 1 month after your last visit to our Website, except where we are legally required to keep the personal data or where it is retained for any other purpose.
E. Information about the use of our Website
Alembic collects information automatically obtained by the Website related to the identification of the California Customer’s computer equipment, use and navigation habits. Said information includes:
Online information regarding language, pages or sections of the Website, keywords, date, time, amount of time the User expends;
IP Address;
Information related to the use of the Website;
Cookie data;
We use this Personal Information based on our legitimate interest to improve our products and services. We will keep the Personal Information for 1 month from the date of the last visit to the Website.
Alembic may combine your Personal Information with other provided by the California Customer or collected from the Website as above mentioned. In those cases, all combined information will be processed as Personal Information during the period the information remains combined.
F. Information provided in “Join us” section
When completing the registry process included in the section “Join us”, the California Customer will provide the following categories of Personal Information:
CV, academic and professional information;
Contact and identity information.
Personal Information provided will be processed in order to take part in the recruitment procedure, as well as for commercial communication in case the California Customer has shown express consent. Personal Information for these purposes shall remain for 1 year from the end of the recruitment process. The legal basis for the processing of these personal data is consent, when California Customer provide their Personal Information for the management of the job vacancy.
G. Services maintenance and optimization
Personal Information related to identifiers; IT and online information; inferred or derived information; etc. will also be used for the maintenance and analysis of our Website, solve any problem, improve availability and protect the Website against fraud.
Analytics also allow us to check whether the online services we offer work effectively in order to improve them whenever possible. California Customer Personal Information for these purposes is based on our legitimate interest and will be retained for a maximum period of 6 months.
H. Comply with our legal obligation
We may need to process your Personal Information to comply with legal obligations binding or accepted by us. Likewise, we may need to provide information to and as required by local law enforcement agencies, government authorities, or otherwise required by law or to protect the rights and safety of our property, company, employees and customers.
Personal Information that may be needed to collect for comply with requirements and legal obligations may include:
Contact and identity information;
Compliance details;
Relationship information;
Commercial information;
Customer’s identifiers;
Health or other sensitive details;
Any other that may be required by authorities.
The User undertakes to use the services and utilities provided by the Website in accordance with current legislation, these Terms and Conditions and moral standards, good practice and public order.
3. HOW WE SHARE YOUR PERSONAL INFORMATION
Sometimes it is necessary to share your Personal Information with other Alembic subsidiaries, companies of the Alembic Pharmaceuticals or third parties in order to guarantee the correct provision of the Website. We may share such information with the following:
Alembic Pharmaceuticals companies due to the use of shared computer systems, which may be located in the European Economic Area (EEA) or in third countries.
Business partners who offer products or services jointly with Alembic.
Service providers, to the extent necessary for the provision of a service.
Such entities may be located in Spain, other countries in the EEA or anywhere else in the world. When we keep Personal Information outside the EEA and territories where CCPA applies, we guarantee an adequate level of protection of the transferred Personal Information. To this purpose, we require service providers to take appropriate measures to protect the confidentiality and security of Personal Information.
For example, for services provided by providers outside the European Economic Area, we use Standard Model Clauses approved by the European Commission.
Alembic may disclose California Customer’s Personal Information to any public administration, when required by law and compelled to do so by such authorities. All data communications will always be carried out in compliance with the applicable data protection law in.
4. SECURITY
Alembic cares to ensure the security and confidentiality of your Personal Information. Therefore, we have implemented several security measures and technical means to prevent the loss, misuse or access to the personal data without the California Customer permission in accordance with the national data protection laws and the GDPR.
Nevertheless, it is also the California Customer responsibility to control his or her Personal Information, therefore Alembic asks and encourages all users to be careful sharing information and content. Alembic shall not control the content and information the California Customer chooses to share with other users and, therefore, Alembic is not responsible for the consequences of the California Customer own actions.
Alembic pledges (i) to act rapidly and in a responsible manner in the event the California Customers Personal Information security is deemed at risk, and (ii) to report it if relevant with the greatest diligence.
In case of security incidents, Alembic undertakes to notify the relevant Privacy agency or authority without undue delay after becoming aware of such breach. Likewise, when the personal data breach is likely to result in a high risk to the rights and freedoms of California Customer, Alembic will communicate the personal information breach and the measures taken to mitigate the risks and adverse effects to California Customer.
5. COOKIES
Much of the information referred to in this California Privacy Policy is collected through the use of cookies. Cookies are small text files containing small amounts of information that are downloaded and can be stored on your user device, for example, your computer, smartphone or tablet. These cookies are sometimes necessary to remember your account settings, language and country, but they also allow us to track and analyse the California Customer’s behaviour on our Website and to display personalised advertisements on our Website or on third party websites. Where necessary, you will be asked to consent to the use of cookies. To obtain additional information on how cookies are used on the Website and its deactivation please visit the Cookies Policy.
6. MINORS
The Website is not intended to be used by minor children. Under no circumstances will Alembic voluntarily collect Personal Information from minors.
7. WE DO NOT SELL YOUR PERSONAL INFORMATION
According to the CCPA, you have the right to know whether your Personal Information is being sold or share with other purposes. Through this Policy Alembic informs you that any Personal Information provided or collected will be sell or share with third parties for monetary purposes.
8. CALIFORNIA CUSTOMER RIGHTS
As California Customer you have the rights, among other, to know, receive or delete your Personal Information.
Alembic enables California Customers to exercise their Personal Information’ rights recognized by the CCPA. Therefore, the California Customer may have the following right concerning the use of Personal Information:
Right to Know and Access Personal Information. You have the right to request:
The categories of Personal Information we have collected, the business purposes for its collection, the categories of third parties with whom we share it and the categories of Personal Information we have shared.
A copy of specific pieces Personal Information we have collected from you.
Right to Correct inaccurate Personal Information. You have the right to request the modification and correction of inaccurate Personal Information collected.
Right to Delete. You have the right to ask for the deletion of your Personal Information. However, in certain situation this deletion will not be possible, such as when it is necessary to complete transactions, comply legal obligations or requirements, provide goods or services requested by you; or to otherwise use your personal information in a lawful manner that is reasonable aligned with your relationship with us and compatible with the context in which you provided your information.
Right Not to Be Subject to Discrimination.
Right to Limit Use and Disclosure of Sensitive Personal Information. You have the right to limit the use of Personal Information provided and request Alembic not to disclosure for different and subsequently purposes unless you provide your consent.
Notwithstanding above-mentioned, California Customer may exercise at any time any other right recognized by the CCPA. Should you exercise any of your privacy rights under the CCPA, Alembic will not discriminate against you by offering different pricing or products, level of quality or other consequences arising from toy request.
For the exercise of any of the abovementioned rights, the California Customer shall contact Alembic by email, addressing the request to compliance@alembictx.com, indicating as reference: “EXERCISE OF RIGHTS” and identifying at the right to be exercised. If we are successful in validating your identity, we will respond to you within the time and in the manner required by the CCPA. In case we cannot validate your identity, Alembic will attempt to contact you to inform.
9. PRIVACY UPDATES
Alembic reserves the right, at its sole discretion, to modify or replace this California Privacy Policy. When this happens, a notice will be included on the Website indicating and informing Users that modifications have been made.
Please review this agreement every so often in order to acknowledge any possible modifications.
10. CONTACT INFORMATION
If you have any further questions about the use of your personal data or about our Privacy Policy, you can contact Alembic Pharmaceutical's DPO by email through compliance@alembictx.com
California Consumer Privacy Act (CCPA) Requests
If you wish to make a request pursuant to the California Consumer Privacy Act (CCPA), please call 1-973-324-0200 or email info@alembictx.com.
